To investigate NfL and GFAP as biomarkers for disease severity in MSA, multiple linear regression analysis was performed to predict UMSARS scores using either GFAP or NfL as biomarker in CSF or plasma, respectively, adjusting for age as confounder. This evidence concerns the gene NEFL and multiple system atrophy.